Three year results of the prostatic urethral L.I.F.T. study

Canadian Journal of Urology

Volumn 22, Issue 3, 2015, Pages 7772-7782

  Roehrborn, Claus G ^a   Rukstalis, Daniel B ^b   Barkin, Jack ^c   Gange, Steven N ^d   Shore, Neal D ^e   Giddens, Jonathan L ^f   Bolton, Damien M ^g   Cowan, Barrett E ^h   Cantwell, Anthony L ⁱ   McVary, Kevin T ^j   Te, Alexis E ^k   Gholami, Shahram S ^l   Moseley, William G ^m   Chin, Peter T ⁿ   Dowling, William T ^o   Freedman, Sheldon J ^p   Incze, Peter F ^q   Coffield, K Scott ^r   Borges, Fernando D ^s   Rashid, Prem ^t  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

^c Toronto Urology Clinical Study Group   (Canada)

^d Western Urological Clinic   (United States)

^e Carolina Urologic Research   (United States)

^f Jonathan Giddens Medicine Professional Corporation   (Canada)

^g AUSTIN HEALTH   (Australia)

^h Urology Associates of Denver   (United States)

ⁱ Advanced Urology Institute   (United States)

^j SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k WEILL CORNELL MEDICAL CENTER   (United States)

^l Pediatric Orthopaedics Associates of Silicon Valley   (United States)

^m Genesis Research LLC   (United States)

ⁿ Illawarra Urology   (Australia)

^o Chesapeake Urology Associates   (United States)

^p Sheldon J Freedman MD Ltd   (United States)

^q The Fe Male Health Centres   (Canada)

^r SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^s Pinellas Urology   (United States)

^t Urology Centre   (Australia)

more..

Author keywords

BPH; Minimally invasive; Sexual function; Surgery; Surgical therapy

Indexed keywords

ADVERSE EFFECTS; AGED; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; CYSTOSCOPY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PROSTATE; PROSTATE HYPERTROPHY; PROSTATISM; PROSTHESES AND ORTHOSES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SEVERITY OF ILLNESS INDEX; SEXUALITY; TREATMENT OUTCOME; URETHRA; URODYNAMICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CYSTOSCOPY; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATISM; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; REOPERATION; SEVERITY OF ILLNESS INDEX; SEXUALITY; TREATMENT OUTCOME; URETHRA; URODYNAMICS;

EID: 84932131194     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wei J, Calhoun E, Jacobsen S. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005;173(4):1256-1261.
2. Norman R, Nickel J, Fish D, Pickett S. 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br J Urol 1994;74(5):542-550.
3. Verhamme K, Dieleman J, Bleumink G, Bosch J, Stricker B, Sturkenboom M. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol 2003;44(5):539-545.
4. Roehrborn C, McConnell J, Barry M et al. American Urological Association Guideline: Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research Inc. 2003.
5. Reich O, Gratzke C, Bachmann A et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180(1):246-249.
6. Bachmann A, Tubaro A, Barber N et al. A European multicenter randomized noninferiority trial comparing 180 W Greenlight- XPS laser vaporization and transurethral resection of the prostate for the treatment of benign obstruction: 12-month results of the GOLIATH study. J Urol 2015;193(2):1-9.
7. McVary K, Roehrborn C, Avins A et al. Update on AUA guideline on the management of benign prostate hyperplasia. J Urol 2011; 185(5):1793-1803.
8. Thangasamy I, Chalasani V, Bachmann A, Woo H. Photoselective vaporization of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012;62(2):315-323.
9. Roehrborn C, Gange S, Shore N et al. Multi-center randomized controlled blinded study of the prostatic urethral lift for the treatment of LUTS associated with prostate enlargement due to BPH: the L.I.F.T. study. J Urol 2013;190(6):2161-2167.
10. McNicholas T, Woo H, Chin P et al. Minimally invasive prostatic urethral lift: surgical technique and multinational study. Eur Urol 2013;64(2):292-299.
11. Barkin J, Giddens J, Incze P, Casey R, Richardson S, Gange S. UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol 2012;19(2):6217-6222.
12. Cantwell A, Bogache W, Richardson S et al. Multi-center prospective crossover study of the prostatic urethral life for the treatment of LUTS secondary to BPH. BJU Int 2013;113(4): 615-622.
13. Shore N, Freedman S, Gange S et al. Prospective multi-center study elucidating patient experience after prostatic urethral lift. Can J Urol 2014;21(1):7094-7101.
14. Woo H, Chin P, McNicholas T et al. Safety and feasibility of the prostatic urethral lift: a novel minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 2011;108(1):82-88.
15. Chin P, Bolton D, Jack G et al. Prostatic urethral lift: two-year results after treatment for lower urinary symptoms secondary to benign prostatic hyperplasia. Urology 2012;79(1):5-11.
16. Roehrborn C, Gange S, Shore N et al. Durability of the prostatic urethral lift: 2-year results of the L.I.F.T. study. Urology Practice 2015;2(1):26-32.
17. Sonksen J, Barber N, Speakman M et al. Prospective, randomized, multinational study of the prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 2015;Published online May 1, 2015.
18. McVary K, Gange S, Shore N et al. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of the prostatic urethral lift. J Sex Med 2014;11(1):279-287.
19. Bell J, Laborde E. Update on sexual impact of treatment for benign prostatic hyperplasia. Curr Urol Rep 2012;13(6):433-440.
20. Grino P, Bruskewitz R, Blaivis J et al. Maximum urinary flow rate by uroflowmetry: automatic or visual interpretation. J Urol 1993;149(2):339-341.
21. Roehrborn C, Wilson T, Black L. Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial. J Urol 2012;187(5):1732-1738.
22. Miranda E, Gomes C, Torricelli F et al. Nocturia is the lower urinary tract symptom with greatest impact on quality of life of men from a community setting. Int Neurourol J 2014;18(2):86-90.
23. Ushijima S, Ukimura O, Okihara K, Mizutani Y, Kawauchi A, Miki T. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score. J Urol 2006;176(2):665-671.
24. Helgason A, Adolfsson J, Dickman P, Fredrikson M, Arver S, Steineck G. Waning sexual function-the most important diseasespecific distress for patients with prostate cancer. Br J Cancer 1996; 73(11):1417-1421.
25. Roos NP, Wennberg JE, Malenka DJ et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 320(17):1120-1124.
26. Madersbacher S, Lackner J, Brossner C et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide long-term analysis of 23,123 cases. Eur Urol 2005;47(4): 499-504.
27. Mamoulakis C, Schulze M, Skolarikos A et al. Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol 2013;63(4):667-676.
28. Tabatabaei S, Choi B, Collins E et al. 120W Greenlight laser prostatectomy-one year data from an ongoing prospective multicentre study (International Greenlight Users Group-IGLU). J Urol 2010;184(4): e740.
29. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello A. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20(8):580-585.
30. Taşçi, A.I., Olbey Y, Luleci H et al. 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology 2011;78 (1):134-140.
31. Ruszat R, Seitz M, Wyler S F et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54(4): 893-901.
32. Ruszat R, Wyler S F, Seitz M et al. Comparison of potassium-titanylphosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008;102(10):1432-1438.
33. Rieken M, Ebinger Mundorff N, Bonkat G, Wyler S, Bachmann A. Complications of laser prostatectomy: a review of recent data. World J Urol 2010;28(1):53-62.
34. Bouza C, Lopez T, Magro A, Navalpotro L, Amate J. Systematic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol 2006;6:14.
35. Hoffman R, Monga M, Elliott S et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev 2012; 9:CD004135.